메뉴 건너뛰기




Volumn 55, Issue 11, 2016, Pages 2085-2087

Successful treatment of life-threatening autoimmune haemolytic anaemia with ofatumumab in a patient with systemic lupus erythematosus

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CYCLOSPORIN A; EPINEPHRINE; HAPTOGLOBIN; HEMOGLOBIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; OFATUMUMAB; RITUXIMAB; STEROID; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

EID: 84997427333     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kew267     Document Type: Article
Times cited : (9)

References (6)
  • 1
    • 84949193256 scopus 로고    scopus 로고
    • Haematological manifestations of lupus
    • Fayyaz A, Igoe A, Kurien BT et al. Haematological manifestations of lupus. Lupus Sci Med 2015;2: e000078.
    • (2015) Lupus Sci Med , vol.2 , pp. e000078
    • Fayyaz, A.1    Igoe, A.2    Kurien, B.T.3
  • 2
    • 84877838218 scopus 로고    scopus 로고
    • Management of immune cytopenias in patients with systemic lupus erythematosus-Old and new
    • Newman K, Bagher Owlia M, El-Hemaidi I, Akhtari M. Management of immune cytopenias in patients with systemic lupus erythematosus-Old and new. Autoimmun Rev 2013;12:784-91.
    • (2013) Autoimmun Rev , vol.12 , pp. 784-791
    • Newman, K.1    Bagher Owlia, M.2    El-Hemaidi, I.3    Akhtari, M.4
  • 3
    • 84880715556 scopus 로고    scopus 로고
    • Ofatumumab in rituximabrefractory autoimmune hemolytic anemia associated with chronic lymphocytic leukemia: A case report and review of literature
    • Nader K, Patel M, Ferber A. Ofatumumab in rituximabrefractory autoimmune hemolytic anemia associated with chronic lymphocytic leukemia: a case report and review of literature. Clin Lymphoma Myeloma Leuk 2013;13:511-3.
    • (2013) Clin Lymphoma Myeloma Leuk , vol.13 , pp. 511-513
    • Nader, K.1    Patel, M.2    Ferber, A.3
  • 4
    • 84860390375 scopus 로고    scopus 로고
    • Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biologicalnaive, rheumatoid arthritis patients with an inadequate response to methotrexate: A randomised, double-blind, placebo-controlled clinical trial
    • Taylor PC, Quattrocchi E, Mallett S et al. Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biologicalnaive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trial. Ann Rheum Dis 2011;70:2119-25.
    • (2011) Ann Rheum Dis , vol.70 , pp. 2119-2125
    • Taylor, P.C.1    Quattrocchi, E.2    Mallett, S.3
  • 5
    • 84896930767 scopus 로고    scopus 로고
    • Ofatumumab for rituximab-resistant nephrotic syndrome
    • Biswanath B. Ofatumumab for rituximab-resistant nephrotic syndrome. N Engl J Med 2014;370:1268-70.
    • (2014) N Engl J Med , vol.370 , pp. 1268-1270
    • Biswanath, B.1
  • 6
    • 84941660589 scopus 로고    scopus 로고
    • Ofatumumab: A novel treatment for severe systemic lupus erythematosus
    • Thornton CC, Ambrose N, Ioannou Y. Ofatumumab: a novel treatment for severe systemic lupus erythematosus. Rheumatology 2015;54:559-560.
    • (2015) Rheumatology , vol.54 , pp. 559-560
    • Thornton, C.C.1    Ambrose, N.2    Ioannou, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.